NASDAQ · Healthcare · Biotechnology
Alzamend Neuro, Inc.
ALZN
Alzamend Neuro, Inc. CEO Stephan Jackman · Market cap $3.2M.
$1.03
+0.01 · +0.98%
52w hi $8.2252w lo $0.84
Off 52w high 86.5%
63
NOTABLE
Current InsiderScore
Corp · 90d
1
1 buys · 0 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
1
0 strong · 1 notable
Analyst consensus
Strong Buy
—
Section 01
Recent Form 4 filings
1 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| Apr 14 | AULT MILTON C III | Buy | 108,388 | $1.00 | +$109K | 63 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
JunJulAugSepOctNovDecJanFebMarAprMay